Michael R. Megna, Chief Accounting Officer: Kiniksa Pharmaceuticals International KNSA Sell · Filed 23/12/21

Trade details

Type: Insider sale
Amount: $178,215.08
Shares · price: 9,316 sh · $19.13 a share
Held after: 17,005 sh
Stock: Kiniksa Pharmaceuticals International KNSA
Person: Michael R. MegnaChief Accounting Officer
Trade date: 23/12/19
Filed: 23/12/21
Days to filing: 2 days

Sold 35.4% of holdings

Share of holding sold: 35.4%

Kiniksa Pharmaceuticals International trades, last 26 weeks

What else happened in Kiniksa Pharmaceuticals International around then

Filed or reported within 30 days of the trade day · 23/11/19~24/01/18

Michael R. Megna's recent trades

Michael R. MegnaChief Accounting Officer
Planned sale10b5-1 planKiniksa Pharmaceuticals International
Planned sale10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$369.4K
4,600 sh
$369.4K
Filed 09/03
Traded 09/03
Michael R. MegnaChief Accounting Officer
Sell10b5-1 planKiniksa Pharmaceuticals International
Sell10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$309.3K
6,625 sh
$309.3K
Filed 04/13
Traded 04/09
Michael R. MegnaChief Accounting Officer
Planned sale10b5-1 planKiniksa Pharmaceuticals International
Planned sale10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$309.3K
6,625 sh
$309.3K
Filed 04/09
Traded 04/09
Michael R. MegnaChief Accounting Officer
Sell10b5-1 planKiniksa Pharmaceuticals International
Sell10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$1.4M
37,255 sh
$1.4M
Filed 25/10/22
Traded 25/10/20
Michael R. MegnaChief Accounting Officer
Sell10b5-1 planKiniksa Pharmaceuticals International
Sell10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$520.3K
13,235 sh
$520.3K
Filed 25/10/22
Traded 25/10/20